Back

Introduction.

26 August 2022 (15:30 - 15:35)
Organised by:
Congress Presentation Part of: New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo
Professor Lina Badimon

Medical School, University of Vic-UCC and IRSI-CC, CIBERCV, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
ASCVD & residual risk: recent clinical insights with icosapent ethyl.
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
A continuum of multifactorial benefits of icosapent ethyl.
Professor M. Back (Stockholm, SE)
Slides Video
Presentation thumbnail
Integrating icosapent ethyl in clinical practice: which patients will benefit?
Professor S. Verma (Toronto, CA)
Slides Video
Presentation thumbnail
Discussion.
Professor L. Badimon (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Perspectives on the results of recent clinical outcome trials with icosapent ethyl
27 August 2023
thumbnail
Congress Presentation
Looking at the past of Preventive Cardiology in Europe
14 April 2023
thumbnail
Congress Presentation
Metabolic signature of prevalent cardiovascular diseases
31 August 2025
thumbnail
Congress Presentation
Introduction
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources